Skip to contentI
Insight Molecular Diagnostics Inc.
I
IMDXInsight Molecular Diagnostics Inc. Q1 2020 · 10-Q
Revenue$16.00K$16.00Kno prior Q1 2019 on file Net Income-$7.73M-$7.73MN/M vs Q1 2019 EPS Diluted-$0.13-$0.13N/M vs Q1 2019 Operating Income-$8,431,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
Free Cash Flowderived-$6,914,000N/M Margins · derivedOperating margin-52693.8%
Net margin-48325.0%
ended Mar 31, 2020 · filed May 12, 2020 · 42 d after period end